Identification of somatic mutations in parathyroid tumors using whole-exome sequencing

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Cromer, M Kyle ^a   Starker, Lee F ^a,c   Choi, Murim ^a   Udelsman, Robert ^a   Nelson Williams, Carol ^a   Lifton, Richard P ^a   Carling, Tobias ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CHROMOSOME 11; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENHANCER OF ZESTE HOMOLOG 2 GENE; EXOME; GENE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; HETEROZYGOSITY LOSS; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULAR PATHOLOGY; MULTIPLE ENDOCRINE NEOPLASIA 1 GENE; MUTATION RATE; NONSENSE MUTATION; PARATHYROID TUMOR; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SOMATIC MUTATION; VALIDATION PROCESS; WILD TYPE;

ADENOMA; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROID NEOPLASMS; POLYCOMB REPRESSIVE COMPLEX 2; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA;

EID: 84866170767     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1743     Document Type: Article

References (48)

1. Lundgren E, Rastad J, Thrufjell E, Akerströöm G, Ljunghall S 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287-294 (Pubitemid 27114448)
2. Verdonk CA, Edis AJ 1981 Parathyroid "double adenomas": fact or fiction? Surgery 90:523-526 (Pubitemid 11061984)
3. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM 2007 Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109:1736-1741 (Pubitemid 46668534)
4. Carling T 2001 Molecular pathology of parathyroid tumors. Trends Endocrinol Metab 12:53-58 (Pubitemid 33714189)
5. Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A 1998 Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab 83:1766-1770 (Pubitemid 28501056)
6. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729 (Pubitemid 37315009)
7. Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa, J, Gallagher J, Wild Y, Saucier K 2002 Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N30-N36 (Pubitemid 35222310)
8. Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A 1994 p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320-1324
9. Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery Jr AL, Benedict WF, Arnold A 1994 Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757-761 (Pubitemid 24080222)
10. Gejman R, Batista DL, Zhong Y, Zhou Y, Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET, Klibanski A 2008 Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 93:4119-4125
11. Carling T, Du Y, Fang W, Correa P, Huang S 2003 Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134:932-939; discussion 939-940
12. Starker LF, Svedlund J, Udelsman R, Dralle H, Akerström G, Westin G, Lifton RP, Björklund P, Carling T 2011 The DNA methylome of benign and malignant parathyroid tumors. Genes Chromosomes Cancer 50:735-745
13. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL 2004 Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102:749-754
14. + channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768-772
15. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloǧlu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP 2009 Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 106:19096-19101
16. Li H, Ruan J, Durbin R 2008 Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18:1851-1858
17. Li H, Durbin R 2009 Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-1760
18. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup 2009 The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079
19. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA 2010 Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181-185
20. Björklund P, Akerström G, Westin G 2007 An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/β-catenin signaling. PLoS Med 4:e328
21. Starker LF, Fonseca A, Akerstrom G, Bjorklund P, Westin G, Carling T 11 May 2012 Evidence of a stabilizing mutation β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. Endocrine 10.1007/s12020-012-9690-3
22. Gyan E, Frew M, Bowen D, Beldjord C, Preudhomme C, Lacombe C, Mayeux P, Dreyfus F, Porteu F, Fontenay M 2005 Mutation in RAP1 is a rare event in myelodysplastic syndromes. Leukemia 19:1678-1680 (Pubitemid 43090418)
23. Lemos MC, Thakker RV 2008 Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22-32
24. Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, Rastad J, Westin G, Akerström G 1998 Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab 83:2960-2963 (Pubitemid 28493806)
25. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ 1997 Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16:375-378 (Pubitemid 27323304)
26. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tönnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH 2010 Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 42:665-667
27. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV, Waghorn K, Zoi K, Ross FM, Reiter A, Hochhaus A, Drexler HG, Duncombe A, Cervantes F, Oscier D, Boultwood J, Grand FH, Cross NCP 2010 Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 42:722-726
28. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH, Thakker RV 1998 Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62:232-244 (Pubitemid 28110764)
29. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC 1998 Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95:1630-1634 (Pubitemid 28103444)
30. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S, Xian CZ, Khodei S, Teh BT, Lagercrantz J, Siggers P, Calender A, Van de Vem V, Kas K, Weber G, Hayward N, Gaudray P, Larsson C 1998 Characterization of the mouse Men1 gene and its expression during development. Oncogene 17:2485-2493 (Pubitemid 28544718)
31. Guru SC, Prasad NB, Shin EJ, Hemavathy K, Lu J, Ip YT, Agarwal SK, Marx SJ, Spiegel AM, Collins FS, Oliver B, Chandrasekharappa SC 2001 Characterization of a MEN1 ortholog from Drosophila melanogaster. Gene 263:31-38 (Pubitemid 32167051)
32. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407
33. Kim H, Lee JE, Cho EJ, Liu JO, Youn HD 2003 Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res 63:6135-6139 (Pubitemid 37255151)
34. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC, Hayes DN, Shanmugam KS, Bhattacharjee A, Biondi CA, Kay GF, Hayward NK, Hess JL, Meyerson M 2004 Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13:587-597 (Pubitemid 38299385)
35. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96:143-152 (Pubitemid 29044161)
36. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN 2001 Inactivation of menin, a Smad3-interactng protein, blocks transforming growth factor type β signaling. Proc Natl Acad Sci USA 98:3837-3842 (Pubitemid 32249858)
37. Heppner C, Bilimoria KY, Agarwhal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL 2001The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20:4917-4925 (Pubitemid 32769781)
38. Ratineau C, Bernard C, Poncet G, Blanc M, Josso C, Fontanière S, Calender A, Chayvialle JA, Zhang CX, Roche C 2004 Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J Biol Chem 279:24477-24484 (Pubitemid 38725312)
39. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, La P, Hua X 2004 Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem 279:10685-10691 (Pubitemid 38372681)
40. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD, Hua X 2003 Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63:4204-4210 (Pubitemid 36917947)
41. Harding B, Lemos MC, Reed AA, Walls GV, Jeyabalan J, Bowl MR, Tateossian H, Sullivan N, Hough T, Fraser WD, Ansorge O, Cheeseman MT, Thakker RV 2009 Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia. Endocr Relat Cancer 16:1313-1327
42. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA, Garrett-Beal L, Burns AL, Ried T, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23:6075-6085 (Pubitemid 37013087)
43. Martinez-Garcia E, Licht JD 2010 Deregulation of H3K27 methylation in cancer. Nat Genet 42:100-101
44. van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J, Butler A, Hinton J, Latimer C, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Cole J, Forbes S, Jia M, Jones D, Kok CY, Leroy C, Lin ML, et al. 2009 Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41:521-523
45. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM 2002 The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629
46. Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, Marquez VE, Marra MA, Gascoyne RD, Humphries RK, Arrowsmith CH, Morin GB, Aparicio SA 2011 Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117:2451-2459
47. Wu X, Hua X 2008 Menin, histone 3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective. Curr Mol Med 8:805-815
48. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, Shows TB, Kronenberg HM 1989 Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034-2040 (Pubitemid 19148876)